The present review on HIV-associated neurocognitive disorders (HAND) provides a
worldwide overview of studies that have investigated the rate and neuropsychological (NP) …

Subtyping patients into subgroups based on biotypes has emerged as a useful approach for
studying heterogeneous diseases. Understanding biotypes of HIV-associated …

Importance Despite the introduction of combination antiretroviral therapy (cART), HIV-
associated neurocognitive disorders continue to be a problem for treated HIV-positive …

HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral
suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive …

Abstract Purpose of Review The purpose of this review was to examine characteristics that
may distinguish HIV-associated neurocognitive disorder (HAND) from early Alzheimer's …

Background High antiretroviral therapy (ART) coverage and viral suppression among
people with HIV (PWH) in Australia provide a unique context to study individual cognitive …

With the advent of virally suppressive antiretroviral therapy (ART), life expectancy for
persons with human immunodeficiency virus (HIV) with access to ART now approaches that …

HIV-associated neurocognitive disorders (HAND) continue to affect a large proportion of
persons living with HIV despite effective viral suppression with combined antiretroviral …

Suppression of HIV replication by antiretroviral therapy (ART) or host immunity can prevent
AIDS but not other HIV-associated conditions including neurocognitive impairment (HIV …

Background The longitudinal rate and profile of cognitive decline in persons with stable,
treated, and virally suppressed HIV infection is not established. To address this question, the …